<SEC-DOCUMENT>0001157523-12-004025.txt : 20120731
<SEC-HEADER>0001157523-12-004025.hdr.sgml : 20120731
<ACCEPTANCE-DATETIME>20120731080024
ACCESSION NUMBER:		0001157523-12-004025
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20120731
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20120731
DATE AS OF CHANGE:		20120731

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MEDNAX, INC.
		CENTRAL INDEX KEY:			0000893949
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-HOSPITALS [8060]
		IRS NUMBER:				650271219
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-12111
		FILM NUMBER:		12995293

	BUSINESS ADDRESS:	
		STREET 1:		1301 CONCORD TERRACE
		CITY:			SUNRISE
		STATE:			FL
		ZIP:			33323
		BUSINESS PHONE:		9543840175

	MAIL ADDRESS:	
		STREET 1:		1301 CONCORD TERRACE
		CITY:			SUNRISE
		STATE:			FL
		ZIP:			33323

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PEDIATRIX MEDICAL GROUP INC
		DATE OF NAME CHANGE:	19950801
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>a50360390.htm
<DESCRIPTION>MEDNAX, INC. 8-K
<TEXT>
<html>
  <head>
    <title></title>
<!--Copyright 2012 Business Wire, a Berkshire Hathaway company.-->
<!--All rights reserved www.businesswire.com-->
  </head>
  <body style="font-family: Times New Roman; font-size: 10pt">
    <p>

    </p>
    <p style="text-align: center">
      <font style="font-size: 11pt; font-family: Times New Roman"><b>UNITED
      STATES</b></font><b><font style="font-size: 11pt; font-family: Times New Roman"><br style="font-family: Times New Roman; font-size: 11pt"></font><font style="font-size: 11pt; font-family: Times New Roman">SECURITIES
      AND EXCHANGE COMMISSION</font></b><font style="font-size: 11pt"><br style="font-size: 11pt"></font><font style="font-size: 11pt; font-family: Times New Roman"><b>Washington,
      D.C. 20549</b></font><font style="font-size: 11pt"><br style="font-size: 11pt"></font><font style="font-size: 11pt"><br style="font-size: 11pt"></font><font style="font-size: 11pt; font-family: Times New Roman"><b>FORM
      8-K</b></font><font style="font-size: 11pt"><br style="font-size: 11pt"></font><font style="font-size: 11pt"><br style="font-size: 11pt"></font><font style="font-size: 11pt; font-family: Times New Roman"><b>CURRENT
      REPORT</b></font><font style="font-size: 11pt"><br style="font-size: 11pt"></font><font style="font-size: 11pt"><br style="font-size: 11pt"></font><font style="font-size: 11pt; font-family: Times New Roman"><b>
      Pursuant to Section 13 or 15(d) of the</b></font><font style="font-size: 11pt"><br style="font-size: 11pt"></font><font style="font-size: 11pt; font-family: Times New Roman"><b>Securities
      Exchange Act of 1934</b></font><font style="font-size: 11pt"><br style="font-size: 11pt"></font><font style="font-size: 11pt"><br style="font-size: 11pt"></font><font style="font-size: 11pt; font-family: Times New Roman"><b>Date
      of Report (date of earliest event reported): July 31, 2012</b></font><font style="font-size: 11pt"><br style="font-size: 11pt"></font><font style="font-size: 11pt"><br style="font-size: 11pt"></font><u><font style="font-size: 11pt; font-family: Times New Roman"><b>MEDNAX,
      INC.</b></font></u><font style="font-size: 11pt"><br style="font-size: 11pt"></font><font style="font-size: 11pt; font-family: Times New Roman"><b>(Exact
      Name of Registrant as Specified in Its Charter)</b></font><br><br>
    </p>
<div style="text-align:left">
    <table style="font-family: Times New Roman; width: 100%; margin-bottom: 10.0px; font-size: 10pt" cellspacing="0">
      <tr>
        <td style="border-bottom: solid black 1.0pt; padding-left: 0.0px; text-align: center; width: 32%" valign="bottom">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>Florida</b>
          </p>
        </td>
        <td style="width: 2%">
          &#160;
        </td>
        <td style="border-bottom: solid black 1.0pt; padding-right: 0.0px; padding-left: 0.0px; text-align: center; width: 32%; white-space: nowrap" valign="bottom">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>001-12111</b>
          </p>
        </td>
        <td style="width: 2%">
          &#160;
        </td>
        <td style="border-bottom: solid black 1.0pt; padding-right: 0.0px; padding-left: 0.0px; text-align: center; width: 32%; white-space: nowrap" valign="bottom">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>26-3667538</b>
          </p>
        </td>
      </tr>
      <tr>
        <td style="padding-left: 0.0px; text-align: center; width: 32%" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>(State or Other Jurisdiction of</b>
          </p>
          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>Incorporation)</b>
          </p>
        </td>
        <td style="width: 2%">

        </td>
        <td style="padding-left: 0.0px; text-align: center; width: 32%" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>(Commission File</b>
          </p>
          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>Number)</b>
          </p>
        </td>
        <td style="width: 2%">

        </td>
        <td style="padding-left: 0.0px; text-align: center; width: 32%" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>(IRS Employer Identification No.)</b>
          </p>
        </td>
      </tr>
    </table>
    </div>
<div style="text-align:left">
    <table style="font-family: Times New Roman; width: 100%; margin-bottom: 10.0px; font-size: 10pt" cellspacing="0">
      <tr>
        <td style="width: 25%">
          &#160;
        </td>
        <td style="border-bottom: solid black 1.0pt; padding-left: 0.0px; text-align: center; width: 50%" valign="bottom">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>1301 Concord Terrace</b>
          </p>
          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>Sunrise, Florida 33323</b>
          </p>
        </td>
        <td style="padding-left: 0.0px; text-align: center; width: 25%; padding-bottom: 2.0px" valign="bottom">
          <p style="margin-bottom: 0px; margin-top: 0px">
            &#160;
          </p>
        </td>
      </tr>
      <tr>
        <td style="width: 25%">

        </td>
        <td style="padding-left: 0.0px; text-align: center; width: 50%" valign="bottom">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <font style="font-size: 10pt; font-family: Times New Roman"><b>(Address
            of principal executive office) (zip code)</b></font>
          </p>
        </td>
        <td style="padding-left: 0.0px; text-align: center; width: 25%" valign="bottom">
          <p style="margin-bottom: 0px; margin-top: 0px">
            &#160;
          </p>
        </td>
      </tr>
    </table>
    </div>
    <p style="text-align: left">
      <br>
      <font style="font-size: 10pt; font-family: Times New Roman"><b>Registrant&#8217;s
      telephone number, including area code </b></font><b><u>(954) 384-0175</u></b><br>
    </p>
    <hr style="height: 1.0 pt; color: #000000; text-align: center; width: 100%">
    <hr style="height: 1.0 pt; color: #000000; text-align: center; width: 100%">


    <p>

    </p>
    <p>
      <font style="font-size: 10pt; font-family: Times New Roman">Check the
      appropriate box below if the Form 8-K filing is intended to
      simultaneously satisfy the filing obligation of the registrant under any
      of the following provisions:</font>
    </p>
    <p>
      <font style="font-size: 10pt; font-family: Arial Unicode MS">&#8414;</font>
      <font style="font-size: 10pt; font-family: Times New Roman">Written
      communications pursuant to Rule 425 under the Securities Act (17 CFR
      230.425)</font>
    </p>
    <p>
      <font style="font-size: 10pt; font-family: Arial Unicode MS">&#8414;</font>
      <font style="font-size: 10pt; font-family: Times New Roman">Soliciting
      material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
      240.14a-12)</font>
    </p>
    <p>
      <font style="font-size: 10pt; font-family: Arial Unicode MS">&#8414;</font>
      <font style="font-size: 10pt; font-family: Times New Roman">Pre-commencement
      communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
      240.14d-2(b))</font>
    </p>
    <p>
      <font style="font-size: 10pt; font-family: Arial Unicode MS">&#8414;</font>
      <font style="font-size: 10pt; font-family: Times New Roman">Pre-commencement
      communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
      240.13e-4(c))</font>
    </p>
    <div style="margin-left: 0pt; width: 100%; margin-bottom: 10pt; margin-right: 0pt; text-indent: 0pt">
      <div>
        <div style="text-align: left">

        </div>
      </div>
      <div style="page-break-after: always">
        <div style="text-align: center">

        </div>
        <div style="text-align: center">
          <hr style="height: 1.5pt; color: black">

        </div>
      </div>
      <div>
        <div style="text-align: right">

        </div>
      </div>
    </div>
<div style="text-align:left">
    <table style="font-family: Times New Roman; width: 100%; margin-bottom: 10.0px; font-size: 10pt" cellspacing="0">
      <tr>
        <td style="padding-left: 0.0px; text-align: left; width: 12%" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>Item 2.02</b>
          </p>
        </td>
        <td style="padding-left: 0.0px; text-align: left; width: 88%" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>Results of Operations and Financial Condition.</b>
          </p>
        </td>
      </tr>
    </table>
    </div>
    <p>
      On July 31, 2012, MEDNAX, Inc., a Florida corporation (the &#8220;Company&#8221;),
      issued a press release announcing the results of its operations for the
      three months and six months ended June 30, 2012 (the &#8220;Second Quarter
      Release&#8221;).&#160;&#160;A copy of the Second Quarter Release is attached hereto as
      Exhibit 99.1 and is hereby incorporated in this Current Report by
      reference.&#160;&#160;The information contained in this Item 2.02, including
      Exhibit 99.1, shall not be deemed &#8220;filed&#8221; with the Securities and
      Exchange Commission nor incorporated by reference in any registration
      statement or other document filed by the Company under the Securities
      Act of 1933, as amended, except as shall be expressly set forth by
      specific reference in such filing.&#160;&#160;
    </p>
<div style="text-align:left">
    <table style="font-family: Times New Roman; width: 100%; margin-bottom: 10.0px; font-size: 10pt" cellspacing="0">
      <tr>
        <td style="padding-left: 0.0px; text-align: left; width: 12%" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>Item 9.01</b>
          </p>
        </td>
        <td colspan="2" style="padding-left: 0.0px; text-align: left" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>Financial Statements and Exhibits.</b>
          </p>
        </td>
      </tr>
      <tr>
        <td style="padding-left: 0.0px; text-align: left; width: 12%" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(d)</b>
          </p>
        </td>
        <td style="padding-left: 0.0px; text-align: left; width: 2%" valign="top">
          &#160;
        </td>
        <td style="padding-left: 0.0px; text-align: left; width: 86%" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>Exhibits.</b>
          </p>
        </td>
      </tr>
      <tr>
        <td style="padding-left: 0.0px; text-align: left; width: 12%" valign="top">

        </td>
        <td style="padding-left: 0.0px; text-align: left; width: 2%" valign="top">

        </td>
        <td style="padding-left: 0.0px; text-align: left; width: 86%" valign="top">
          99.1&#8212;Press Release of MEDNAX, Inc. dated July 31, 2012.
        </td>
      </tr>
    </table>
    </div>
    <div style="margin-left: 0pt; width: 100%; margin-bottom: 10pt; margin-right: 0pt; text-indent: 0pt">
      <div>
        <div style="text-align: left">

        </div>
      </div>
      <div style="page-break-after: always">
        <div style="text-align: center">

        </div>
        <div style="text-align: center">
          <hr style="height: 1.5pt; color: black">

        </div>
      </div>
      <div>
        <div style="text-align: right">

        </div>
      </div>
    </div>
    <p>

    </p>
    <p style="text-align: center">
      <font style="font-size: 10pt; font-family: Times New Roman"><b>SIGNATURES</b></font>
    </p>
    <p style="text-align: justify; text-indent: 30.0px">
      <font style="font-size: 10pt; font-family: Times New Roman">Pursuant to
      the requirements of the Securities Exchange Act of 1934, the registrant
      has duly caused this report to be signed on its behalf by the
      undersigned hereunto duly authorized.</font>
    </p>
<div style="text-align:left">
    <table style="font-family: Times New Roman; width: 100%; margin-bottom: 10.0px; font-size: 10pt" cellspacing="0">
      <tr>
        <td style="width: 5%">

        </td>
        <td style="width: 45%">

        </td>
        <td colspan="2" style="padding-left: 0.0px; text-align: left" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>MEDNAX, INC.</b>
          </p>
        </td>
      </tr>
      <tr>
        <td style="width: 5%">

        </td>
        <td style="width: 45%">

        </td>
        <td colspan="2" style="padding-left: 0.0px; text-align: left" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            &#160;
          </p>
        </td>
      </tr>
      <tr>
        <td style="width: 5%">

        </td>
        <td style="width: 45%">

        </td>
        <td colspan="2">
          &#160;
        </td>
      </tr>
      <tr>
        <td style="width: 5%">

        </td>
        <td style="width: 45%">

        </td>
        <td colspan="2">
          &#160;
        </td>
      </tr>
      <tr>
        <td style="padding-left: 0.0px; text-align: left; width: 5%; padding-bottom: 2.0px" valign="top">
          Date:
        </td>
        <td style="padding-left: 0.0px; text-align: left; width: 45%; padding-bottom: 2.0px" valign="top">
          July 31, 2012
        </td>
        <td style="padding-left: 0.0px; text-align: left; width: 4%; padding-bottom: 2.0px" valign="top">
          By:
        </td>
        <td style="border-bottom: solid black 1.0pt; padding-left: 0.0px; text-align: left; width: 46%" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            /s/ Vivian Lopez-Blanco
          </p>
        </td>
      </tr>
      <tr>
        <td style="width: 5%">

        </td>
        <td style="width: 45%">

        </td>
        <td style="width: 4%">

        </td>
        <td style="padding-left: 0.0px; text-align: left; width: 46%" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            Vivian Lopez-Blanco
          </p>
        </td>
      </tr>
      <tr>
        <td style="width: 5%">

        </td>
        <td style="width: 45%">

        </td>
        <td style="width: 4%">

        </td>
        <td style="padding-left: 0.0px; text-align: left; width: 46%" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            Chief Financial Officer
          </p>
        </td>
      </tr>
    </table>
    </div>
    <p>

    </p>
    <div style="margin-left: 0pt; width: 100%; margin-bottom: 10pt; margin-right: 0pt; text-indent: 0pt">
      <div>
        <div style="text-align: left">

        </div>
      </div>
      <div style="page-break-after: always">
        <div style="text-align: center">

        </div>
        <div style="text-align: center">
          <hr style="height: 1.5pt; color: black">

        </div>
      </div>
      <div>
        <div style="text-align: right">

        </div>
      </div>
    </div>
    <p>

    </p>
    <p style="text-align: center">
      <b>EXHIBIT INDEX</b>
    </p>
    <p style="text-align: left">

    </p>
<div style="text-align:left">
    <table style="font-family: Times New Roman; width: 100%; margin-bottom: 10.0px; font-size: 10pt" cellspacing="0">
      <tr>
        <td style="padding-left: 0.0px; text-align: left; width: 12%" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <u><b>Exhibit No.</b></u>
          </p>
        </td>
        <td style="padding-left: 40.0px; text-align: left; width: 88%" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <u><b>Description</b></u>
          </p>
        </td>
      </tr>
      <tr>
        <td style="width: 12%">

        </td>
        <td style="padding-left: 0.0px; text-align: left; width: 88%" valign="top">
          &#160;
        </td>
      </tr>
      <tr>
        <td style="padding-right: 0.0px; padding-left: 0.0px; text-align: left; width: 12%; white-space: nowrap" valign="top">
          99.1
        </td>
        <td style="padding-left: 0.0px; text-align: left; width: 88%" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            Press Release of MEDNAX, Inc. dated July 31, 2012.
          </p>
        </td>
      </tr>
    </table>
    </div>
    <p>

    </p>
  </body>
</html>
<!--<!DOCTYPE html
     PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN"
     "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">-->
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a50360390-ex991.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
<!--Copyright 2012 Business Wire, a Berkshire Hathaway company.-->
<!--All rights reserved www.businesswire.com-->
  </head>
  <body style="font-family: Times New Roman; font-size: 8pt">
    <p style="text-align: right">
      <b>Exhibit 99.1</b>
    </p>
    <p style="text-align: center">
      <font style="font-size: 12pt; font-family: Times New Roman"><b>MEDNAX
      Exceeds Second Quarter Earnings Guidance, Earns $1.22 Per Share for 2012
      Second Quarter</b></font>
    </p>
    <p style="text-align: center">

    </p>
    <p style="text-align: center">
      <i><font style="font-size: 12pt; font-family: Times New Roman"><b>Expects
      Third Quarter EPS of $1.25 to $1.30</b></font></i>
    </p>
    <p>
      FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--July 31, 2012--MEDNAX, Inc.
      (NYSE:MD), the national medical group specializing in neonatal,
      maternal-fetal, pediatric cardiology, other pediatric subspecialties and
      anesthesia physician services, today reported earnings of $1.22 per
      share for the three months ended June 30, 2012.
    </p>
    <p>
      &#8220;We are especially pleased with our results for the quarter, including
      the same unit growth of nearly 4 percent that contributed to our 2012
      second quarter results exceeding our guidance,&#8221; said Roger J. Medel,
      M.D., Chief Executive Officer of MEDNAX. &#8220;On the acquisition front, we
      continue to make solid progress in building our national anesthesia
      group practice, are managing a very full and robust pipeline, and are
      confident in our ability to continue growing through acquisitions across
      all of our physician specialties.&#8221;
    </p>
    <p>
      MEDNAX&#8217;s net patient service revenue for the three months ended June 30,
      2012, increased by 14.3 percent, to $449.5 million, from $393.4 million
      for the comparable prior-year period.
    </p>
    <p>
      MEDNAX&#8217;s revenue growth attributable to contributions from recently
      acquired practices was 10.4 percent, while same-unit revenue grew by 3.9
      percent for the 2012 second quarter when compared to the 2011 second
      quarter.
    </p>
    <div style="margin-left: 0pt; width: 100%; margin-bottom: 10pt; margin-right: 0pt; text-indent: 0pt">
      <div>
        <div style="text-align: left">

        </div>
      </div>
      <div style="page-break-after: always">
        <div style="text-align: center">

        </div>
        <div style="text-align: center">
          <hr style="height: 1.5pt; color: black">

        </div>
      </div>
      <div>
        <div style="text-align: right">

        </div>
      </div>
    </div>
    <p>
      Same-unit growth from net reimbursement-related factors was 2.4 percent.
      This was principally due to continued modest improvements in
      reimbursements received from third-party commercial payors as a result
      of the Company&#8217;s ongoing contract renewal processes, and an increase in
      the administrative fees received from our hospital partners due to the
      expansion of our services as a result of internal growth initiatives,
      partially offset by a shift in payor mix to government payors, from
      commercial payors, year-over-year.
    </p>
    <p>
      Same-unit growth attributable to patient volume grew by 1.5 percent for
      the 2012 second quarter when compared to the prior-year period, and
      includes growth in our hospital-based neonatal and anesthesia services
      as well as other pediatric physician services, primarily newborn nursery
      services, partially offset by slight declines in our office-based
      maternal-fetal and pediatric cardiology services. For the 2012 second
      quarter, same-unit neonatal intensive care unit (NICU) patient days
      increased by 1.4 percent when compared to the prior-year period.
    </p>
    <p>
      The percentage of services reimbursed under government programs shifted
      by approximately 130 basis points toward a higher percentage of services
      reimbursed under government programs for the 2012 second quarter, when
      compared with the prior-year period. Sequentially, however, our
      same-unit payor mix has remained relatively stable since the third
      quarter of 2011.
    </p>
    <p>
      Operating income for the 2012 second quarter was $99.7 million, up 7.1
      percent from $93.1 million for the prior-year period. Operating margin
      decreased to 22.2 percent for the 2012 second quarter, from 23.7 percent
      for the prior-year period, primarily as a result of an increase in
      operating expenses during the 2012 second quarter as compared to the
      2011 second quarter and the variability in margins due to the mix of
      practices acquired since April 2011.
    </p>
    <p>
      General and administrative expenses were 10.7 percent of revenue for the
      2012 second quarter, an improvement of 13 basis points from 10.9 percent
      for the prior-year period.
    </p>
    <p>
      MEDNAX generated net income of $60.5 million for the 2012 second
      quarter, or $1.22 per share based on a weighted average 49.5 million
      shares outstanding. This compares with net income of $55.9 million, or
      $1.15 per share for the 2011 second quarter, based on a weighted average
      48.7 million shares outstanding.
    </p>
    <p>
      Through the first half of 2012, MEDNAX has generated revenue of $872.1
      million, up 12.4 percent from $775.7 million for the prior-year period.
      Operating income for the six months ended June 30, 2012, grew by 6.1
      percent to $179.1 million, up from $168.8 million for the first half of
      2011. MEDNAX earned net income of $108.9 million, or $2.20 per share
      through June 30, 2012, based on a weighted average 49.5 million shares
      outstanding, which compares to net income of $101.4 million, or $2.09
      per share based on a weighted average 48.5 million shares outstanding
      for the first half of 2011.
    </p>
    <p>
      At June 30, 2012, MEDNAX had cash and cash equivalents of $12.1 million
      and net accounts receivable were $240.9 million. The Company had no
      outstanding balance on its $500 million revolving credit facility at
      June 30, 2012.
    </p>
    <p>
      During the 2012 second quarter, MEDNAX generated cash flow from
      operations of $117.1 million.
    </p>
    <div style="margin-left: 0pt; width: 100%; margin-bottom: 10pt; margin-right: 0pt; text-indent: 0pt">
      <div>
        <div style="text-align: left">

        </div>
      </div>
      <div style="page-break-after: always">
        <div style="text-align: center">

        </div>
        <div style="text-align: center">
          <hr style="height: 1.5pt; color: black">

        </div>
      </div>
      <div>
        <div style="text-align: right">

        </div>
      </div>
    </div>
    <p>
      MEDNAX also used $41.3 million of its cash during the 2012 second
      quarter to fund three anesthesiology group practice acquisitions and to
      make contingent purchase price payments for previously completed
      acquisitions. The three anesthesiology group practices acquired by
      MEDNAX during the second quarter are located in Burlington, North
      Carolina; Bryan, Texas; and Fort Lauderdale, Florida.
    </p>
    <p>
      A total of seven physician group practices have been acquired through
      June 30, 2012, with four physician group practices becoming part of
      Pediatrix Medical Group and three group practices becoming part of
      American Anesthesiology.
    </p>
    <p>
      Since the end of the 2012 second quarter, MEDNAX has announced the
      acquisition of two anesthesia physician group practices, one in
      Knoxville, Tennessee and one in Leesburg, Virginia.
    </p>
    <p>
      2012 Third Quarter Outlook
    </p>
    <p>
      For the 2012 third quarter, MEDNAX expects earnings will be in a range
      of $1.25 to $1.30 per share. This range assumes that total same-unit
      revenue for the three months ended September 30, 2012 will grow by 1.0
      percent to 3.0 percent from the prior-year period. This same-unit growth
      forecast is expected to be divided between approximately one-half
      patient volume growth across all MEDNAX physician specialties and
      one-half net reimbursement growth, including improvements from
      commercial contract rates as well as variability in the mix of services
      reimbursed under commercial and government payor programs. This range
      also includes estimated contributions from practices acquired since the
      end of the 2012 second quarter.
    </p>
    <div style="margin-left: 0pt; width: 100%; margin-bottom: 10pt; margin-right: 0pt; text-indent: 0pt">
      <div>
        <div style="text-align: left">

        </div>
      </div>
      <div style="page-break-after: always">
        <div style="text-align: center">

        </div>
        <div style="text-align: center">
          <hr style="height: 1.5pt; color: black">

        </div>
      </div>
      <div>
        <div style="text-align: right">

        </div>
      </div>
    </div>
    <p>
      Earnings conference call
    </p>
    <p>
      MEDNAX, Inc. will host an investor conference call to discuss the
      quarterly results at 10 a.m., E.S.T. today. The conference call Webcast
      may be accessed from the Company&#8217;s Website, <u>www.mednax.com</u>.
      A telephone replay of the conference call will be available from noon
      Eastern Time today through midnight E.S.T. August 14, 2012 by dialing
      800.475.6701, access code 253731. The replay will also be available at <u>www.mednax.com</u>.
    </p>
    <p>
      <b>ABOUT MEDNAX</b>
    </p>
    <p>
      MEDNAX, Inc. is a national medical group that comprises the nation's
      leading provider of neonatal, maternal-fetal and pediatric physician
      subspecialty services as well as anesthesia services. Physicians and
      advanced practitioners practicing as part of MEDNAX are reshaping the
      delivery of care within their specialties and subspecialties, using
      evidence-based tools, continuous quality initiatives and clinical
      research to enhance patient outcomes and provide high-quality,
      cost-effective care. Pediatrix Medical Group, a unit of MEDNAX, was
      founded in 1979 and now includes neonatal physicians who provide
      services at more than 300 neonatal intensive care units, who collaborate
      with affiliated maternal-fetal medicine, pediatric cardiology and
      pediatric critical care physician subspecialists to provide a clinical
      care continuum. Pediatrix is also the nation's largest provider of
      newborn hearing screens. In 2007, MEDNAX expanded into anesthesia
      services. Today, American Anesthesiology includes more than 1,200
      anesthesiologists and advanced practitioners who provide anesthesia care
      to patients in connection with surgical and other procedures as well as
      pain management. MEDNAX, through its affiliated professional
      corporations, employs more than 1,900 physicians in 34 states and Puerto
      Rico. Additional information is available at <u>www.mednax.com</u>.
    </p>
    <p>
      <i>Certain statements and information in this press release may be
      deemed to contain forward-looking statements within the meaning of the
      Private Securities Litigation Reform Act of 1995, Section 27A of the
      Securities Act of 1933, as amended, and Section 21E of the Securities
      Exchange Act of 1934, as amended.</i> <i>Forward-looking statements</i> <i>may
      include, but are not limited to, statements relating to our objectives,
      plans and strategies, and all statements, other than statements of
      historical facts, that address activities, events or developments that
      we intend, expect, project, believe or anticipate will or may occur in
      the future. These statements are often characterized by terminology such
      as &#8220;believe&#8221;, &#8220;hope&#8221;, &#8220;may&#8221;, &#8220;anticipate&#8221;, &#8220;should&#8221;, &#8220;intend&#8221;, &#8220;plan&#8221;,
      &#8220;will&#8221;, &#8220;expect&#8221;, &#8220;estimate&#8221;, &#8220;project&#8221;, &#8220;positioned&#8221;, &#8220;strategy&#8221; and
      similar expressions, and are based on assumptions and assessments made
      by MEDNAX&#8217;s management in light of their experience and their perception
      of historical trends, current conditions, expected future developments
      and other factors they believe to be appropriate. Any forward-looking
      statements in this press release are made as of the date hereof, and
      MEDNAX undertakes no duty to update or revise any such statements,
      whether as a result of new information, future events or otherwise.
      Forward-looking statements are not guarantees of future performance and
      are subject to risks and uncertainties. Important factors that could</i> <i>cause
      actual results, developments, and business decisions to differ
      materially from forward-looking statements are described in MEDNAX&#8217;s
      most recent Annual Report on Form 10-K and its Quarterly Reports on Form
      10-Q, including the sections entitled &#8220;Risk Factors&#8221;, as well MEDNAX&#8217;s
      current reports on Form 8-K,</i> <i>filed with the Securities and
      Exchange Commission.</i>
    </p>
    <div style="margin-left: 0pt; width: 100%; margin-bottom: 10pt; margin-right: 0pt; text-indent: 0pt">
      <div>
        <div style="text-align: left">

        </div>
      </div>
      <div style="page-break-after: always">
        <div style="text-align: center">

        </div>
        <div style="text-align: center">
          <hr style="height: 1.5pt; color: black">

        </div>
      </div>
      <div>
        <div style="text-align: right">

        </div>
      </div>
    </div>
<div style="text-align:left">
    <table style="font-family: Times New Roman; width: 100%; margin-bottom: 10.0px; font-size: 8pt" cellspacing="0">
      <tr>
        <td colspan="13" style="padding-left: 0.0px; text-align: center" valign="top">
          <b>MEDNAX, INC.</b>
        </td>
      </tr>
      <tr>
        <td colspan="13" style="padding-left: 0.0px; text-align: center" valign="top">
          <b>Condensed Consolidated Statements of Income</b>
        </td>
      </tr>
      <tr>
        <td colspan="13" style="padding-left: 0.0px; text-align: center" valign="top">
          <b>(in thousands, except per share data)</b>
        </td>
      </tr>
      <tr>
        <td colspan="13" style="padding-left: 0.0px; text-align: center" valign="top">
          <b>(Unaudited)</b>
        </td>
      </tr>
      <tr>
        <td>

        </td>
        <td>
          &#160;
        </td>
        <td colspan="5">

        </td>
        <td>
          &#160;
        </td>
        <td colspan="5">

        </td>
      </tr>
      <tr>
        <td>

        </td>
        <td>

        </td>
        <td colspan="5" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; text-align: center" valign="top">
          <b>Three Months Ended</b>

          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>June 30,</b>
          </p>
        </td>
        <td>

        </td>
        <td colspan="5" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; text-align: center" valign="top">
          <b>Six Months Ended</b>

          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>June 30,</b>
          </p>
        </td>
      </tr>
      <tr>
        <td>

        </td>
        <td>

        </td>
        <td colspan="2" style="border-bottom: solid black 1.0pt; padding-right: 0.0px; padding-left: 0.0px; text-align: center; white-space: nowrap" valign="bottom">
          <b>2012</b>
        </td>
        <td>
          &#160;
        </td>
        <td colspan="2" style="border-bottom: solid black 1.0pt; padding-right: 0.0px; padding-left: 0.0px; text-align: center; white-space: nowrap" valign="bottom">
          <b>2011</b>
        </td>
        <td>

        </td>
        <td colspan="2" style="border-bottom: solid black 1.0pt; padding-right: 0.0px; padding-left: 0.0px; text-align: center; white-space: nowrap" valign="bottom">
          <b>2012</b>
        </td>
        <td>
          &#160;
        </td>
        <td colspan="2" style="border-bottom: solid black 1.0pt; padding-right: 0.0px; padding-left: 0.0px; text-align: center; white-space: nowrap" valign="bottom">
          <b>2011</b>
        </td>
      </tr>
      <tr>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>
          &#160;
        </td>
      </tr>
      <tr>
        <td style="padding-left: 0.0px; text-align: left; padding-bottom: 2.0px" valign="top">
          Net patient service revenue
        </td>
        <td>

        </td>
        <td style="border-bottom: solid black 1.0pt; padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          $
        </td>
        <td style="border-bottom: solid black 1.0pt; padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          449,530
        </td>
        <td>

        </td>
        <td style="border-bottom: solid black 1.0pt; padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          $
        </td>
        <td style="border-bottom: solid black 1.0pt; padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          393,402
        </td>
        <td>

        </td>
        <td style="border-bottom: solid black 1.0pt; padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          $
        </td>
        <td style="border-bottom: solid black 1.0pt; padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          872,146
        </td>
        <td>

        </td>
        <td style="border-bottom: solid black 1.0pt; padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          $
        </td>
        <td style="border-bottom: solid black 1.0pt; padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          775,685
        </td>
      </tr>
      <tr>
        <td style="padding-left: 0.0px; text-align: left" valign="top">
          Operating expenses:
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
      </tr>
      <tr>
        <td style="padding-left: 10.0px; text-align: left" valign="top">
          Practice salaries and benefits
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          275,951
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          235,292
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          548,212
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          479,186
        </td>
      </tr>
      <tr>
        <td style="padding-left: 10.0px; text-align: left" valign="top">
          Practice supplies and other operating expenses
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          17,956
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          16,253
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          34,941
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          31,343
        </td>
      </tr>
      <tr>
        <td style="padding-left: 10.0px; text-align: left" valign="top">
          General and administrative expenses
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          48,200
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          42,702
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          95,069
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          84,500
        </td>
      </tr>
      <tr>
        <td style="padding-left: 10.0px; text-align: left; padding-bottom: 2.0px" valign="top">
          Depreciation and amortization
        </td>
        <td>

        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td style="border-bottom: solid black 1.0pt; padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          7,687
        </td>
        <td>

        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td style="border-bottom: solid black 1.0pt; padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          6,032
        </td>
        <td>

        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td style="border-bottom: solid black 1.0pt; padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          14,800
        </td>
        <td>

        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td style="border-bottom: solid black 1.0pt; padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          11,813
        </td>
      </tr>
      <tr>
        <td style="padding-left: 30.0px; text-align: left; padding-bottom: 2.0px" valign="top">
          Total operating expenses
        </td>
        <td>

        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td style="border-bottom: solid black 1.0pt; padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          349,794
        </td>
        <td>

        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td style="border-bottom: solid black 1.0pt; padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          300,279
        </td>
        <td>

        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td style="border-bottom: solid black 1.0pt; padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          693,022
        </td>
        <td>

        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td style="border-bottom: solid black 1.0pt; padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          606,842
        </td>
      </tr>
      <tr>
        <td style="padding-left: 0.0px; text-align: left" valign="top">
          Income from operations
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          99,736
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          93,123
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          179,124
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          168,843
        </td>
      </tr>
      <tr>
        <td style="padding-left: 0.0px; text-align: left" valign="top">
          Investment income
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          365
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          329
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          793
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          654
        </td>
      </tr>
      <tr>
        <td style="padding-left: 0.0px; text-align: left; padding-bottom: 2.0px" valign="top">
          Interest expense
        </td>
        <td>

        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td style="border-bottom: solid black 1.0pt; padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          (848)
        </td>
        <td>

        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td style="border-bottom: solid black 1.0pt; padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          (988)
        </td>
        <td>

        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td style="border-bottom: solid black 1.0pt; padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          (1,402)
        </td>
        <td>

        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td style="border-bottom: solid black 1.0pt; padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          (1,899)
        </td>
      </tr>
      <tr>
        <td style="padding-left: 15.0px; text-align: left" valign="top">
          Income before income taxes
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          99,253
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          92,464
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          178,515
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          167,598
        </td>
      </tr>
      <tr>
        <td style="padding-left: 0.0px; text-align: left; padding-bottom: 2.0px" valign="top">
          Income tax provision
        </td>
        <td>

        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td style="border-bottom: solid black 1.0pt; padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          38,709
        </td>
        <td>

        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td style="border-bottom: solid black 1.0pt; padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          36,523
        </td>
        <td>

        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td style="border-bottom: solid black 1.0pt; padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          69,621
        </td>
        <td>

        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td style="border-bottom: solid black 1.0pt; padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          66,201
        </td>
      </tr>
      <tr>
        <td style="padding-left: 0.0px; text-align: left; padding-bottom: 4.0px" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            Net income
          </p>
        </td>
        <td>

        </td>
        <td style="border-bottom: double black 2.25pt; padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          $
        </td>
        <td style="border-bottom: double black 2.25pt; padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          60,544
        </td>
        <td>

        </td>
        <td style="border-bottom: double black 2.25pt; padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          $
        </td>
        <td style="border-bottom: double black 2.25pt; padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          55,941
        </td>
        <td>

        </td>
        <td style="border-bottom: double black 2.25pt; padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          $
        </td>
        <td style="border-bottom: double black 2.25pt; padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          108,894
        </td>
        <td>

        </td>
        <td style="border-bottom: double black 2.25pt; padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          $
        </td>
        <td style="border-bottom: double black 2.25pt; padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          101,397
        </td>
      </tr>
      <tr>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>
          &#160;
        </td>
      </tr>
      <tr>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>
          &#160;
        </td>
      </tr>
      <tr>
        <td style="padding-left: 0.0px; text-align: left; padding-bottom: 4.0px" valign="top">
          Net income per common and common

          <p style="margin-bottom: 0px; margin-top: 0px">
            equivalent share (diluted)
          </p>
        </td>
        <td>

        </td>
        <td style="border-bottom: double black 2.25pt; padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          $
        </td>
        <td style="border-bottom: double black 2.25pt; padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          1.22
        </td>
        <td>

        </td>
        <td style="border-bottom: double black 2.25pt; padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          $
        </td>
        <td style="border-bottom: double black 2.25pt; padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          1.15
        </td>
        <td>

        </td>
        <td style="border-bottom: double black 2.25pt; padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          $
        </td>
        <td style="border-bottom: double black 2.25pt; padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          2.20
        </td>
        <td>

        </td>
        <td style="border-bottom: double black 2.25pt; padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          $
        </td>
        <td style="border-bottom: double black 2.25pt; padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          2.09
        </td>
      </tr>
      <tr>
        <td style="padding-left: 0.0px; text-align: left; padding-bottom: 4.0px" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            Weighted average shares used in computing
          </p>
          <p style="margin-bottom: 0px; margin-top: 0px">
            net income per common and common
          </p>
          <p style="margin-bottom: 0px; margin-top: 0px">
            equivalent share (diluted)
          </p>
        </td>
        <td>

        </td>
        <td style="border-bottom: double black 2.25pt">
          &#160;
        </td>
        <td style="border-bottom: double black 2.25pt; padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          49,545
        </td>
        <td>

        </td>
        <td style="border-bottom: double black 2.25pt">
          &#160;
        </td>
        <td style="border-bottom: double black 2.25pt; padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          48,730
        </td>
        <td>

        </td>
        <td style="border-bottom: double black 2.25pt">
          &#160;
        </td>
        <td style="border-bottom: double black 2.25pt; padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          49,474
        </td>
        <td>

        </td>
        <td style="border-bottom: double black 2.25pt">
          &#160;
        </td>
        <td style="border-bottom: double black 2.25pt; padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          48,547
        </td>
      </tr>
      <tr>
        <td colspan="13">
          &#160;
        </td>
      </tr>
    </table>
    </div>
    <div style="margin-left: 0pt; width: 100%; margin-bottom: 10pt; margin-right: 0pt; text-indent: 0pt">
      <div>
        <div style="text-align: left">

        </div>
      </div>
      <div style="page-break-after: always">
        <div style="text-align: center">

        </div>
        <div style="text-align: center">
          <hr style="height: 1.5pt; color: black">

        </div>
      </div>
      <div>
        <div style="text-align: right">

        </div>
      </div>
    </div>
<div style="text-align:left">
    <table style="font-family: Times New Roman; width: 100%; margin-bottom: 10.0px; font-size: 8pt" cellspacing="0">
      <tr>
        <td colspan="7" style="padding-left: 0.0px; text-align: center" valign="bottom">
          <b>Balance Sheet Highlights</b>

          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>(in thousands)</b>
          </p>
        </td>
      </tr>
      <tr>
        <td colspan="7" style="padding-left: 0.0px; text-align: center" valign="bottom">
          <b>(Unaudited)</b>
        </td>
      </tr>
      <tr>
        <td colspan="7">
          &#160;
        </td>
      </tr>
      <tr>
        <td>

        </td>
        <td>
          &#160;
        </td>
        <td colspan="2" style="padding-left: 0.0px; text-align: center" valign="bottom">
          <b>As of</b>
        </td>
        <td>
          &#160;
        </td>
        <td colspan="2" style="padding-left: 0.0px; text-align: center" valign="bottom">
          <b>As of</b>
        </td>
      </tr>
      <tr>
        <td>

        </td>
        <td>

        </td>
        <td colspan="2" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; text-align: center" valign="bottom">
          <b>June 30, 2012</b>
        </td>
        <td>

        </td>
        <td colspan="2" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; text-align: center" valign="bottom">
          <b>December 31, 2011</b>
        </td>
      </tr>
      <tr>
        <td style="padding-left: 0.0px; text-align: left" valign="bottom">
          <b>Assets:</b>
        </td>
        <td>

        </td>
        <td colspan="2">

        </td>
        <td>

        </td>
        <td colspan="2">

        </td>
      </tr>
      <tr>
        <td style="padding-left: 0.0px; text-align: left" valign="bottom">
          Cash and cash equivalents
        </td>
        <td>

        </td>
        <td style="padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          $
        </td>
        <td style="padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          12,146
        </td>
        <td>

        </td>
        <td style="padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          $
        </td>
        <td style="padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          18,596
        </td>
      </tr>
      <tr>
        <td style="padding-left: 0.0px; text-align: left" valign="bottom">
          Short-term investments
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          3,317
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          4,139
        </td>
      </tr>
      <tr>
        <td style="padding-left: 0.0px; text-align: left" valign="bottom">
          Accounts receivable, net
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          240,920
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          230,388
        </td>
      </tr>
      <tr>
        <td style="padding-left: 0.0px; text-align: left" valign="bottom">
          Other current assets
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          83,840
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          84,150
        </td>
      </tr>
      <tr>
        <td style="padding-left: 0.0px; text-align: left; padding-bottom: 2.0px" valign="bottom">
          Goodwill, other assets, property and equipment
        </td>
        <td>

        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td style="border-bottom: solid black 1.0pt; padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          2,006,743
        </td>
        <td>

        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td style="border-bottom: solid black 1.0pt; padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          1,935,375
        </td>
      </tr>
      <tr>
        <td style="padding-left: 0.0px; text-align: left; padding-bottom: 4.0px" valign="bottom">
          Total assets
        </td>
        <td>

        </td>
        <td style="border-bottom: double black 2.25pt; padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          $
        </td>
        <td style="border-bottom: double black 2.25pt; padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          2,346,966
        </td>
        <td>

        </td>
        <td style="border-bottom: double black 2.25pt; padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          $
        </td>
        <td style="border-bottom: double black 2.25pt; padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          2,272,648
        </td>
      </tr>
      <tr>
        <td>

        </td>
        <td>

        </td>
        <td colspan="2">

        </td>
        <td>

        </td>
        <td colspan="2">
          &#160;
        </td>
      </tr>
      <tr>
        <td style="padding-left: 0.0px; text-align: left" valign="bottom">
          <b>Liabilities and shareholders&#8217; equity:</b>
        </td>
        <td>

        </td>
        <td colspan="2">

        </td>
        <td>

        </td>
        <td colspan="2">

        </td>
      </tr>
      <tr>
        <td style="padding-left: 0.0px; text-align: left" valign="bottom">
          Accounts payable &amp; accrued expenses
        </td>
        <td>

        </td>
        <td style="padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          $
        </td>
        <td style="padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          180,408
        </td>
        <td>

        </td>
        <td style="padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          $
        </td>
        <td style="padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          234,535
        </td>
      </tr>
      <tr>
        <td style="padding-left: 0.0px; text-align: left" valign="bottom">
          Total debt
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          384
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          29,470
        </td>
      </tr>
      <tr>
        <td style="padding-left: 0.0px; text-align: left; padding-bottom: 2.0px" valign="bottom">
          Other liabilities
        </td>
        <td>

        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td style="border-bottom: solid black 1.0pt; padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          296,061
        </td>
        <td>

        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td style="border-bottom: solid black 1.0pt; padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          277,627
        </td>
      </tr>
      <tr>
        <td style="padding-left: 0.0px; text-align: left" valign="bottom">
          Total liabilities
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          476,853
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          541,632
        </td>
      </tr>
      <tr>
        <td style="padding-left: 0.0px; text-align: left; padding-bottom: 2.0px" valign="bottom">
          Shareholders' equity
        </td>
        <td>

        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td style="border-bottom: solid black 1.0pt; padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          1,870,113
        </td>
        <td>

        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td style="border-bottom: solid black 1.0pt; padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          1,731,016
        </td>
      </tr>
      <tr>
        <td style="padding-left: 0.0px; text-align: left; padding-bottom: 4.0px" valign="bottom">
          Total liabilities and shareholders' equity
        </td>
        <td>

        </td>
        <td style="border-bottom: double black 2.25pt; padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          $
        </td>
        <td style="border-bottom: double black 2.25pt; padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          2,346,966
        </td>
        <td>

        </td>
        <td style="border-bottom: double black 2.25pt; padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          $
        </td>
        <td style="border-bottom: double black 2.25pt; padding-right: 0.0px; padding-left: 0.0px; text-align: right; white-space: nowrap" valign="bottom">
          2,272,648
        </td>
      </tr>
      <tr>
        <td colspan="7">
          &#160;
        </td>
      </tr>
    </table>
    </div>
    <p style="text-align: center">

    </p>
    <p>
      CONTACT:<br><b>MEDNAX, Inc.</b><br>David T. Parker, 954-384-0175, Ext.
      5300<br>Vice President, Investor Relations &amp; Corporate Communications<br><u>david_parker@mednax.com</u>
    </p>
    <p>

    </p>
  </body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
